Morgan Stanley reiterated coverage on Avanos Medical with a new price target

8/4/21 8:34:35 AM ET

Industrial Specialties

Health Care

Morgan Stanley reiterated coverage of Avanos Medical with a rating of Underweight and set a new price target of $41.00 from $45.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AVNS

Date	Price Target	Rating	Analyst
7/25/2023		Overweight → Sector Weight	KeyBanc Capital Markets
5/22/2023	$31.00	Buy	CL King
2/24/2022	$47.00 → $41.00	Overweight	Keybanc
1/7/2022	$37.00 → $36.00	Underweight	Morgan Stanley
8/4/2021	$45.00 → $41.00	Underweight	Morgan Stanley
8/4/2021	$60.00 → $45.00	Overweight → Equal-Weight	Stephens
8/4/2021	$55.00 → $47.00	Overweight	Keybanc